Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Idasanutlin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114349585A details a copper-catalyzed asymmetric synthesis of chiral alpha-deuterated pyrrolidines using D2O, offering cost reduction in pharmaceutical intermediate manufacturing.